Chengda Pharmaceuticals Hits Day High with 6.17% Surge in Stock Price

Chengda Pharmaceuticals Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.17% on March 10, 2026. The stock reached an intraday high of CNY 45.47, reflecting a strong day of trading for the mid-cap company within the Pharmaceuticals & Biotechnology sector. Over the past week, Chengda Pharmaceuticals has outperformed the China Shanghai Composite, with a weekly gain of 8.46% compared to the index's marginal increase of 0.01%. The company's one-month performance stands at an impressive 18.8%, while its year-to-date performance is also notable at 11.15%. Despite these short-term gains, the company faces challenges in terms of management efficiency, as indicated by a low Return on Capital Employed (ROCE) of 7.29%. Additionally, the company has reported negative results for the last four consecutive quarters, with a concerning decline in operating profit. Chengda Pharmaceuticals continues to navigate a complex market landscape, with its stock performance reflecting both recent activity and underlying financial metrics.